Ignite Creation Date:
2024-10-25 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06627465
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-06-25
Brief Title:
Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Connect-MS
Brief Summary:
The Connect-MS is multicentre real-world observational cohort study wherin the outcomes of standard care digital monitoring of 700 patients with multiple sclerosis including all subtypes are recorded over a follow-up period of two years Patients use the MS sherpa and NeuroKeys applications Outcomes are related to the utilisation of digital biomarkers including the adherence to digital monitoring and the impact digital outcomes have on clinical decision making the effect of digital monitoring on healthcare consumption and the ability of these technological biomarkers to detect clinical outcomes on the short and long term Most recorded variables are part of the standard care however participants of this study are also subject to additional questionnaires regarding the consumption of healthcare and the influence of digital monitoring on decision making during clinical consultation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None